Search results
Added:
3 years ago
Can screening patients routinely for atrial fibrillation (AF) before it is diagnosed, help to prevent stroke occurrence by prescribing anticoagulation to those with discovered AF?
Dr Steven Lubitz (Massachusetts General Hospital, Boston, MA, US) discusses the results of the VITAL-AF trial which assessed the effectiveness of screening for undiagnosed atrial fibrillation (AF) using simple,…
View more
Author(s):
Erik Klok
Added:
4 years ago
Dr Erik Klok (Leiden University Medical Center, Leiden, NL)discusses strategies and challenges for developing treatment pathways for pulmonary embolism.
Questions:
How do you approach building a PERT network to establish a path of treatment for patients with pulmonary embolism?
Why and how best do you involve interventional and non-interventionalists in the decision-making processes to…
View more
Michael J Mack
Author
Christian Hamm
Author
Author(s):
Harriette Van Spall
,
Amrita Mukhopadhyay
Added:
1 year ago
ACC.23/WCC — Join Late-Breaker host, Dr Harriette Van Spall(McMaster University, CA) and investigator, Dr Amrita Mukhopadhyay(NYU School of Medicine, US) in their engaging discussion on the BETTER CARE-HF trial (NCT05275920).
The BETTER CARE-HF trial investigated the effectiveness of two electronic clinical decision support (CDS) tools to support prescribing proven therapies for heart failure…
View more
Jean-Claude Deharo
Author
Foreword
Author(s):
Juan Carlos Kaski
Added:
3 years ago
Article
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
7 months ago
What is hot at ESC 2023?
In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the hot line and late-breaking data presented at ESC Congress 2023.
With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.
Top trials…
View more
Author(s):
Jozine ter Maaten
Added:
7 months ago
ESC 2023 — Dr Jozine Ter Maaten (University Medical Centre Groningen, NL) joins us to outline the findings from the PUSH-AHF Study (NCT04606927).
PUSH-AHF (University Medical Center Groningen) aimed to assess the effect of natriuresis-guided therapy in patients with acute heart failure to improve diagnostic response, decongestion and clinical outcomes. 310 patients with a primary diagnosis of…
View more
Author(s):
Shelley Zieroth
,
,
Added:
2 years ago
Following the release at ESC 2021 of updated guidelines for the diagnosis and treatment of acute and chronic heart failure, Dr Shelley Zieroth (University of Manitoba, CA), Prof Hiddo L Heerspink (University Medical Center, Groningen, NL) andProf Kamlesh Khunti (University of Leicester, UK) discuss the implications for practice.
This three-part series, 'SGLT-2 Inhibitors and Cardio-renal…
View more